(HealthDay)—Lucemyra (lofexidine hydrochloride) has been approved by the U.S. Food and Drug Administration to treat symptoms of opioid withdrawal. Lucemyra,
Continue reading »
mypharmacynews.com
Home » Medications »
(HealthDay)—Lucemyra (lofexidine hydrochloride) has been approved by the U.S. Food and Drug Administration to treat symptoms of opioid withdrawal. Lucemyra,
Continue reading »(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now
Continue reading »(HealthDay)—Retacrit (epoetin alfa-epbx) has been approved by the U.S. Food and Drug Administration as the first “biosimilar” to the anemia
Continue reading »The Senate Health, Education, Labor and Pensions Committee unanimously approved a bill in April 2018 designed to address the opioid
Continue reading »In a pilot study published in JAMA Internal Medicine, Yale researchers significantly reduced doses of opioid painkillers given to hospital
Continue reading »(HealthDay)—Production issues have made EpiPens hard to find in some areas of the United States, the U.S. Food and Drug
Continue reading »The story line sounds familiar: a popular pain drug becomes a new way to get high as prescribing by doctors
Continue reading »Australian paramedics are leading the world by introducing a new drug, droperidol, to quickly and safely calm violent patients fueled
Continue reading »(HealthDay)—Overdose deaths involving dangerous synthetic opioids like fentanyl have skyrocketed in recent years, surpassing deaths from prescription painkillers, a new
Continue reading »A new study led by Johns Hopkins researchers adds to growing evidence that patients underuse nonopioid pain relievers to supplement
Continue reading »